Anhedonia: Its dynamic relations with craving, negative affect, and treatment during a quit smoking attempt

Nicotine and Tobacco Research

Volumn 19, Issue 6, 2017, Pages 703-709

  Cook, Jessica W ^a,b   Lanza, Stephanie T ^c   Chu, Wanghuan ^c   Baker, Timothy B ^a   Piper, Megan E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; PLACEBO; NICOTINE; NICOTINE GUM;

ADULT; AFFECT; ANHEDONIA; ARTICLE; CONTROLLED STUDY; CRAVING; DISEASE ASSOCIATION; ECOLOGICAL MOMENTARY ASSESSMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NICOTINE REPLACEMENT THERAPY; PLEASURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; ANHEDONIA; BUPROPION; CRAVING; FEMALE; HUMANS; MALE; NICOTINE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 85020178237     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw247     Document Type: Article

References (54)

1. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol. 2003;112(1):3-13.
2. Zhou X, Nonnemaker J, Sherrill B, Gilsenan AW, Coste F, West R. Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav. 2009;34(4):365-373.
3. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994;271(8):589-594.
4. McCarthy DE, Piasecki TM, Fiore MC, Baker TB. Life before and after quitting smoking: an electronic diary study. J Abnorm Psychol. 2006;115(3):454-466.
5. Bolt DM, Piper ME, Theobald WE, Baker TB. Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol. 2012;80(1):54-65.
6. Piper ME, Federmen EB, McCarthy DE, et al. Using mediational models to explore the nature of tobacco motivation and tobacco treatment effects. J Abnorm Psychol. 2008;117(1):94-105.
7. Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35(1):68-77.
8. Treadway MT, Zald DH. Parsing anhedonia: translational models of reward-processing deficits in psychopathology. Curr Dir Psychol Sci. 2013;22(3):244-249.
9. Franken IH, Rassin E, Muris P. The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). J Affect Disord. 2007;99(1-3):83-89.
10. Cook JW, Spring B, McChargue D, Hedeker D. Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine Tob Res. 2004;6(1):39-47.
11. Cook JW, Piper ME, Leventhal AM, Schlam TR, Fiore MC, Baker TB. Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol. 2015;124(1):215-225.
12. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9(3):315-327.
13. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB. Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations. J Abnorm Psychol. 2003;112(1):14-27.
14. Welsch SK, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol. 1999;7(4):354-361.
15. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295-2303.
16. Siegel S. Classical conditioning, drug tolerance, and drug dependence. In: Smart RG, Glaser FB, Israel Y, Kalant R, Popham E, Schmidt W, eds. Research Advances in Alcohol and Drug Problems. 7th ed. New York: Plenum; 1983:207-246.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
18. Baker TB, Piper ME, Schlam TR, et al. Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol. 2012;121(4):909-921.
19. Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33-51.
20. Swan GE, Jack LM, Javitz HS, McAfee T, McClure JB. Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. CNS Drugs. 2008;22(3):239-256.
21. Dawkins L, Acaster S, Powell JH. The effects of smoking and abstinence on experience of happiness and sadness in response to positively valenced, negatively valenced, and neutral film clips. Addict Behav. 2007;32(2):425-431.
22. Powell J, Dawkins L, Davis RE. Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model. Biol Psychiatry. 2002;51(2):151-163.
23. Powell JH, Pickering AD, Dawkins L, West R, Powell JF. Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict Behav. 2004;29(7):1407-1426.
24. D'Souza MS, Markou A. Neural substrates of psychostimulant withdrawal-induced anhedonia. Curr Top Behav Neurosci. 2010;3:119-178.
25. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998;393(6680):76-79.
26. al-Adawi S, Powell J. The influence of smoking on reward responsiveness and cognitive functions: a natural experiment. Addiction. 1997;92(12):1773-1782.
27. Dawkins L, Powell JH, West R, Powell J, Pickering A. A double-blind placebo controlled experimental study of nicotine: I-effects on incentive motivation. Psychopharmacology (Berl). 2006;189(3):355-367.
28. Kalamboka N, Remington B, Glautier S. Nicotine withdrawal and reward responsivity in a card-sorting task. Psychopharmacology (Berl). 2009;204(1):155-163.
29. Dawkins L, Powell J. Effects of nicotine and alcohol on affective responses to emotionally toned film clips. Psychopharmacology (Berl). 2011;216(2):197-205.
30. Snuggs S, Hajek P. Responsiveness to reward following cessation of smoking. Psychopharmacology (Berl). 2013;225(4):869-873.
31. Hilario MR, Turner JR, Blendy JA. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology. 2012;37(12):2661-2670.
32. Johnson PM, Hollander JA, Kenny PJ. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav. 2008;90(3):409-415.
33. Perkins KA, Karelitz JL. Reinforcement enhancing effects of nicotine via smoking. Psychopharmacology (Berl). 2013;228(3):479-486.
34. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1-32.
35. Hendricks PS, Ditre JW, Drobes DJ, Brandon TH. The early time course of smoking withdrawal effects. Psychopharmacology (Berl). 2006;187(3):385-396.
36. Lanza ST, Vasilenko SA, Liu X, Li R, Piper ME. Advancing the understanding of craving during smoking cessation attempts: a demonstration of the time-varying effect model. Nicotine Tob Res. 2014;16(Suppl 2):S127-S134.
37. Li R, Dziak JD, Tan X, Huang L, Wagner AT, Yang J. TVEM (Time-Varying Effect Modeling) SAS Macro Users' Guide (Version 3.1.0). University Park: The Methodology Center, Penn State; 2015.
38. Tan X, Shiyko MP, Li R, Li Y, Dierker L. A time-varying effect model for intensive longitudinal data. Psychol Methods. 2012;17(1):61-77.
39. Piper ME, Schlam TR, Cook JW, et al. Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl). 2011;216(4):569-578.
40. Piper ME, Smith SS, Schlam TR, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009;66(11):1253-1262.
41. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
42. Baker TB, Piper ME, McCarthy DE, et al. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res. 2007;9(Suppl 4):S555-S570.
43. Bolt DM, Piper ME, McCarthy DE, et al. The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res. 2009;11(5):481-492.
44. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791-799.
45. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063-1070.
46. Fawcett J, Clark DC, Scheftner WA, Gibbons RD. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry. 1983;40(1):79-84.
47. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167(1):99-103.
48. Shiyko MP, Lanza ST, Tan X, Li R, Shiffman S. Using the time-varying effect model (TVEM) to examine dynamic associations between negative affect and self confidence on smoking urges: differences between successful quitters and relapsers. Prev Sci. 2012;13(3):288-299.
49. Hughes JR. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res. 2007;9(3):329-339.
50. Schenker N, Gentleman JF. On judging the significance of differences by examining the overlap between confidence intervals. Am Statistician. 2001;55(3):182-186.
51. Solomon RL, Corbit JD. An opponent-process theory of motivation. II. Cigarette addiction. J Abnorm Psychol. 1973;81(2):158-171.
52. Cacioppo JT, Uchino BN, Crites SL, et al. Relationship between facial expressiveness and sympathetic activation in emotion: a critical review, with emphasis on modeling underlying mechanisms and individual differences. J Pers Soc Psychol. 1992;62(1):110-128.
53. Lang PJ, Levin DN, Miller GA, Kozak MJ. Fear behavior, fear imagery, and the psychophysiology of emotion: the problem of affective response integration. J Abnorm Psychol. 1983;92(3):276-306.
54. Rosenberg EL, Ekman P. Coherence Between Expressive and Experiential Systems in Emotion. What the Face Reveals: Basic and Applied Studies of Spontaneous Expression Using the Facial Action Coding System (FACS). New York, NY: Oxford University Press; 1997.